These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7825246)

  • 1. [Chemotherapy of breast cancer: survival and quality of life].
    Grønvold M
    Ugeskr Laeger; 1994 Oct; 156(44):6501. PubMed ID: 7825246
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer.
    Efficace F; Bottomley A
    J Clin Oncol; 2005 Feb; 23(6):1335-6; author reply 1336. PubMed ID: 15718349
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of chemotherapy for survival after recurrent breast cancer. A population based study of patients treated in the 1950's, 1960's and 1970's].
    Cold S; Jensen NV; Brincker H; Rose C
    Ugeskr Laeger; 1994 Oct; 156(44):6507-11. PubMed ID: 7825248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should chemotherapy or endocrine therapy be used as first choice in patients with advanced breast cancer? A status article based on the Cochrane analysis "Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer"].
    Ejlertsen B; Mouridsen H
    Ugeskr Laeger; 2004 Jun; 166(25):2434-6. PubMed ID: 15283108
    [No Abstract]   [Full Text] [Related]  

  • 5. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer.
    Albert US; Koller M; Wagner U; Schulz KD
    Inflamm Res; 2004 Aug; 53 Suppl 2():S136-41. PubMed ID: 15338065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
    J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improved prognosis of breast cancer].
    Andreasen AH; Mouridsen HT; Andersen KW; Lynge E; Madsen M; Olesen KP
    Ugeskr Laeger; 1994 Oct; 156(44):6512-7. PubMed ID: 7825249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic implications of chemotherapy in the treatment of breast cancer.
    O'Brien ME; Smith IE
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):21-6. PubMed ID: 8777253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group.
    Cole BF; Gelber RD; Anderson KM
    Biometrics; 1994 Sep; 50(3):621-31. PubMed ID: 7981389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
    Scott C; Suh J; Stea B; Nabid A; Hackman J
    Am J Clin Oncol; 2007 Dec; 30(6):580-7. PubMed ID: 18091051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of Danish cancer patients 1943-1987. Breast.
    Ewertz M
    APMIS Suppl; 1993; 33():99-106. PubMed ID: 8512744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy in metastasing breast cancer--is it beneficial?].
    Høgsberg IM; Nielsen MM; Cold S; Rose C
    Ugeskr Laeger; 1994 Oct; 156(44):6549-50. PubMed ID: 7825256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible respect of patient quality of life--without reducing survival expectancy--in breast cancer treatment.
    Mathé G
    Biomed Pharmacother; 1998; 52(3):97-100. PubMed ID: 9755801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group.
    Coates A; Forbes J; Simes RJ
    J Clin Oncol; 1993 Oct; 11(10):2050. PubMed ID: 8410129
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark.
    Debess J; Riis JØ; Pedersen L; Ewertz M
    Acta Oncol; 2009; 48(4):532-40. PubMed ID: 19096948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life as a treatment endpoint in metastatic breast cancer.
    Osoba D
    Can J Oncol; 1995 Dec; 5 Suppl 1():47-53. PubMed ID: 8853525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adriamycin--breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1911-5. PubMed ID: 8978796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.